SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,901 | -13.8% | 74,485 | +96.8% | 0.00% | 0.0% |
| Q2 2023 | $1,779,330 | +445.2% | 37,842 | +386.5% | 0.00% | – |
| Q1 2023 | $326,364 | -81.3% | 7,778 | -83.0% | 0.00% | -100.0% |
| Q4 2022 | $1,745,705 | +403.1% | 45,771 | +417.0% | 0.00% | – |
| Q3 2022 | $347,000 | -98.8% | 8,854 | -99.0% | 0.00% | -100.0% |
| Q1 2022 | $27,958,000 | -19.0% | 844,652 | +4.1% | 0.03% | -14.7% |
| Q4 2021 | $34,518,000 | +32.3% | 811,434 | +37.8% | 0.03% | +21.4% |
| Q3 2021 | $26,100,000 | +11.8% | 589,039 | +43.4% | 0.03% | +12.0% |
| Q2 2021 | $23,335,000 | +24.8% | 410,753 | +64.4% | 0.02% | +8.7% |
| Q1 2021 | $18,704,000 | +29.3% | 249,888 | +49.5% | 0.02% | +21.1% |
| Q4 2020 | $14,461,000 | – | 167,157 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |